|
Q4 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Mar 31, 2025
|
|
|---|---|---|
| Current assets | ||
| Cash at banks | ||
| Accounts receivable, net | ||
| Contract assets | ||
| Prepayments | ||
| Deferred offering costs | ||
| Deposits | ||
| Total current assets | ||
| Non-current assets | ||
| Equipment, net | ||
| Prepayments | ||
| Deferred tax assets | ||
| Total non-current assets | ||
| Total assets | ||
| Current liabilities | ||
| Accounts payable | ||
| Due to directors | ||
| Related Party | ||
| Total due to directors | ||
| Accrued expenses | ||
| Amount due to a related party | ||
| Accrued expenses and other payables | ||
| Income tax payable | ||
| Total current liabilities | ||
| Non-current liabilities | ||
| Deferred tax liabilities | ||
| Total non-current liabilities | ||
| Total liabilities | ||
| Shareholders’ equity | ||
| Ordinary shares, 500,000,000 shares authorized; USD0.0001 par value, 16,957,000 and 12,500,000 shares issued and outstanding, as of March 31, 2026 and 2025, respectively | ||
| Additional paid in capital | ||
| (Accumulated losses)/retained earnings | ||
| Total shareholders’ equity | ||
| Total liabilities and shareholders’ equity |
Loading...
